EMG
DRNA

Ellington Management Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Ellington Management Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,900
Closed -$160K – 832
2019
Q1 		$160K Buy
+10,900
New +$160K 0.03% 474